SCHEMBL31569813

SCHEMBL31569813

Cn1nc(I)c2ccnc(Cl)c21

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 1/20 0.36
▸ LMNA P02545 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ APEX1 P27695 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ PMP22 Q01453 1/20 0.33
▸ DYRK1A Q13627 2/20 0.32
▸ DYRK3 O43781 1/20 0.32
▸ CLK1 P49759 1/20 0.32
▸ CLK2 P49760 1/20 0.32
▸ CLK3 P49761 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ DYRK2 Q92630 1/20 0.32
▸ CLK4 Q9HAZ1 1/20 0.32
▸ DYRK4 Q9NR20 1/20 0.32
▸ DYRK1B Q9Y463 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29760873 0.73 ALDH1A1 (0.43) LMNAMAPTMAPK1DYRK1ADYRK3
SCHEMBL23500899 0.73 ALDH1A1 (0.43) LMNAMAPTMAPK1DYRK1ADYRK3
SCHEMBL30164573 0.72 DYRK1A (0.36) MAPTDYRK1ADYRK3CLK1CLK2
SCHEMBL30566171 0.71 RXFP1 (0.39) RXFP1
SCHEMBL13966385 0.71 RXFP1 (0.39) RXFP1
SCHEMBL31227155 0.71 HASPIN (0.36) RXFP1LMNACYP3A4MAPTAPEX1
SCHEMBL31523008 0.70 DUT (0.34) DYRK1A
SCHEMBL23508960 0.69 P2RX7 (0.39) MAPK1PMP22
SCHEMBL16505866 0.69 RXFP1 (0.40) RXFP1LMNACYP3A4MAPTAPEX1
SCHEMBL30791838 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235363-A1 CYCLIN-DEPENDENT KINASE 4 DEGRADERS BLUEPRINT MEDICINES CORPORATION (US) 2025-11-13 — — WO disclosed
WO-2025101588-A1 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS Treeline Biosciences, Inc. (US) 2025-05-15 — — WO disclosed
Send feedback